Key result
Type 1 diabetes patients with diabetic sensorimotor polyneuropathy had a significantly lower LDI FLARE area compared to diabetes patients without neuropathy (1.4 vs 2.4 cm2, p=0.002), though considerable overlap limited its diagnostic performance.
Why the study?
Does laser doppler imaging of axon reflex-mediated neurogenic vasodilatation accurately detect early diabetic sensorimotor polyneuropathy in patients with type 1 diabetes?
Cross-Sectional (n=153)
No
Does laser doppler imaging of axon reflex-mediated neurogenic vasodilatation accurately detect early diabetic sensorimotor polyneuropathy in patients with type 1 diabetes?
Absolute Event Rate: 1.4% vs 2.4%
p-value: p=0.002
Axon reflex-mediated neurogenic vasodilatation measured by laser doppler imaging is a potential biomarker for early small-fibre nerve dysfunction in type 1 diabetes, though its diagnostic accuracy as a standalone test is currently limited.
Lower LDI FLARE area was associated with neuropathy in type 1 diabetes; leaves open its diagnostic value pending prospective validation.
OBJECTIVE: Axon reflex-mediated neurogenic vasodilatation in response to cutaneous heating may reflect early, pre-clinical small fibre dysfunction. We aimed to evaluate the distribution of the vascular flare area measured by laser doppler imaging ("LDI(FLARE) area") in type 1 diabetes and in healthy volunteers. RESEARCH AND METHODS: Concurrent with clinical and electrophysiological examination to classify diabetic sensorimotor polyneuropathy (DSP), LDI(FLARE) area (cm(2)) was determined in 89 type 1 diabetes subjects matched to 64 healthy volunteers. We examined the association and diagnostic performance of LDI with clinical and subclinical measures of DSP and its severity. RESULTS: Compared to the 64 healthy volunteers, the 56 diabetes controls without DSP had significantly lower LDI(FLARE) area (p = 0.006). The 33 diabetes cases with DSP had substantially lower LDI(FLARE) area as compared to controls without DSP (p = 0.002). There was considerable overlap in LDI(FLARE) area between all groups such that the ROC curve had an AUC of 0.72 and optimal sensitivity of 70% for the detection of clinical DSP. Use of a subclinical definition for DSP, according to subclinical sural nerve impairment, was associated with improved AUC of 0.75 and sensitivity of 79%. In multivariate analysis higher HbA1c and body mass index had independent associations with smaller LDI(FLARE) area. CONCLUSIONS: Axon reflex-mediated neurogenic vasodilatation in response to cutaneous heating is a biomarker of early nerve dysfunction in DSP. Its independent association with glycemic exposure in diabetes subjects and both glycemic exposure and BMI in healthy volunteers highlights the existence of small-fibre dysfunction in the natural history of DSP.
No takes yet. Share an insight, caveat, or question.
Nouri et al. (2012) conducted a cross-sectional in Type 1 Diabetes and Diabetic Sensorimotor Polyneuropathy (n=153). Type 1 diabetes with diabetic sensorimotor polyneuropathy vs. Type 1 diabetes without diabetic sensorimotor polyneuropathy was evaluated on LDI FLARE area (cm2) (p=0.002). Type 1 diabetes patients with diabetic sensorimotor polyneuropathy had a significantly lower LDI FLARE area compared to diabetes patients without neuropathy (1.4 vs 2.4 cm2, p=0.002), though considerable overlap limited its diagnostic performance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: